Dermavant Sciences

Dermavant Sciences

  • Founded: 2017
  • Location: Long Beach, CA
  • Employee range: 1 - 10
  • Clinical stage: COM
  • Therapy area: Psoriasis
  • Drug types: DRM, IMM
  • Lead product: VTAMA (DMVT-505)
  • Product link: https://www.dermavant.com/pipeline/
  • Funding: $200M Jun 2021; $100M Aug 2018


dermavant.com

linkedin.com

job board


Short description:

Small Molecules for Dermatology Indications

Drug notes:

Also Clin3 atopic dermatitis; DMVT-506 Clin0 Immunological & inflammatory diseases

Long description:

Dermavant is developing and commercializing therapeutics for medical dermatology. The skin is the largest organ of the body and millions of people globally suffer with chronic skin conditions. Dermavant is building a dermatology pipeline of product candidates that target specific unmet needs in two of the largest growing immuno-dermatology conditions - plaque psoriasis and atopic dermatitis. VTAMA®, Dermavant’s lead candidate is a topical formulation that is an agonist for the aryl hydrocarbon receptor. Recently, Dermavant announced positive results from their Phase 3 trial of VTAMA® for patients with Atopic Dermatitis.

Jobs:

Dermavant Sciences
Field Medical Director (Ohio & Kentucky)
Ohio, United States|8 days ago
Apply
Dermavant Sciences
Territory Business Manager (Sarasota)
Sarasota, FL|9 days ago
Dermavant Sciences
Director, Strategic Finance Analytics
Long Beach, US|51 days ago
Dermavant Sciences
Territory Business Manager (Hartford)
Hartford, US|100 days ago
Dermavant Sciences
Field Medical Director (Dallas)
Dallas, US|100 days ago
Dermavant Sciences
Field Medical Director (Chicago)
Chicago, US|100 days ago


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com